pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase
Targeting therapeutically-relevant proteins for degradation is an emerging paradigm in drug discovery. Here the authors describe a sensitive pulse SILAC mass spectrometry-based proteomics approach that reports global changes in protein stability following drug treatment in a single time point experi...
Enregistré dans:
Auteurs principaux: | Jian An, Charles M. Ponthier, Ragna Sack, Jan Seebacher, Michael B. Stadler, Katherine A. Donovan, Eric S. Fischer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29e7aa9bcbbf457cab317eff9b4c1bbd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide
par: Hirotake Furihata, et autres
Publié: (2020) -
Agentes inmunomoduladores (IMiDs): herramientas para el tratamiento del mieloma múltiple
par: Fernández-Lázaro,Diego, et autres
Publié: (2018) -
Cortical dynamics during cell motility are regulated by CRL3KLHL21 E3 ubiquitin ligase
par: Thibault Courtheoux, et autres
Publié: (2016) -
The RepID–CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation
par: Sang-Min Jang, et autres
Publié: (2020) -
Correction: Corrigendum: Cortical dynamics during cell motility are regulated by CRL3KLHL21 E3 ubiquitin ligase
par: Thibault Courtheoux, et autres
Publié: (2016)